Rich Bagger served from January 2012 through December 2019 as Executive Vice President of Corporate Affairs and Market Access for Celgene Corporation, with responsibility for advancing patient access to Celgene therapies and driving recognition of the value of Celgene innovation through communications, patient advocacy, government relations, public policy, market access, global health and corporate responsibility activities around the world.
While on a leave of absence from Celgene in 2016, Rich served as Executive Director of Trump for America, responsible for pre-election planning for the Presidential transition of Donald J. Trump. Before joining Celgene, Rich served as Chief of Staff for New Jersey Governor Chris Christie, managing implementation of the Governor’s policy agenda and priorities. Since 2012, Rich has served as a Commissioner and Chair of the Finance Committee for the Port Authority of New York and New Jersey. He was also Board Chair of the Gateway Program Development Corporation for 2017.
Previously, Rich was employed by Pfizer Inc for more than 16 years in a series of positions of increasing responsibility within the company’s U.S. Pharmaceuticals, Corporate Affairs and Worldwide Pharmaceuticals Divisions. From 2006 to 2009, he served on Pfizer’s senior most management team as Senior Vice President, Worldwide Public Affairs and Policy. Prior to joining Pfizer, Rich was Assistant General Counsel of Blue Cross and Blue Shield of New Jersey and practiced law with McCarter & English.
Rich’s public service includes ten years in the New Jersey General Assembly, where he chaired the Appropriations Committee and was elected by his colleagues as Majority Conference Leader. In 2001, Rich was elected to the New Jersey Senate and served there until 2003. Before his election to the Legislature, he was a Council Member and Mayor of Westfield, New Jersey.
Rich served as Board Chair of the National Pharmaceutical Council for 2018-2019 and is a member of the Board of Directors of the U.S. Chamber of Commerce, where he chaired the Global Innovation Policy Center from 2014 to 2018. He also serves on the President’s Commission on White House Fellowships, as an Adjunct Faculty member at the Rutgers University Eagleton Institute and on the Advisory Board for the Lerner Center for the Study of Pharmaceutical Management Issues at Rutgers University Business School.
He received an A.B. degree from Princeton University’s Woodrow Wilson School of Public and International Affairs and a J.D. degree from Rutgers University Law School.